NeuroSense Therapeutics Q4 EPS $(0.16) Beats $(0.23) Estimate
NeuroSense Therapeutics Q4 EPS $(0.16) Beats $(0.23) Estimate
NeuroSense Therapeutics第四季度每股收益美元(0.16美元)超過預期(0.23美元)
NeuroSense Therapeutics (NASDAQ:NRSN) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.23) by 30.43 percent. This is a 40.74 percent increase over losses of $(0.27) per share from the same period last year.
NeuroSense Therapeutics(納斯達克股票代碼:NRSN)公佈的季度虧損爲每股0.16美元,比分析師共識估計的美元(0.23美元)高出30.43個百分點。這比去年同期每股虧損0.27美元(0.27美元)增長了40.74%。